Identification of novel drug targets for the risk and prognosis of COVID-19

BACKGROUND: Since the epidemic continues, there is a pressing need to improve our understanding of coronavirus disease 2019 (COVID-19). Mendelian randomization (MR) studies provide us with a method to explore the causality between circulating proteins and COVID-19 susceptibility and severity. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Yi-Han, Ou, Ya-Nan, Yang, Yu-Xiang, Deng, Yue-Ting, Liu, Yi, Tan, Lan, Yu, Jin-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263786/
https://www.ncbi.nlm.nih.gov/pubmed/35813330
http://dx.doi.org/10.21037/atm-21-6612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263786/
https://www.ncbi.nlm.nih.gov/pubmed/35813330
http://dx.doi.org/10.21037/atm-21-6612

Ejemplares similares